A high oocyte yield for intracytoplasmic sperm injection treatment is associated with an increased chromosome error rate

Fertil Steril. 2009 Mar;91(3):733-8. doi: 10.1016/j.fertnstert.2008.01.012. Epub 2008 Mar 7.

Abstract

Objective: To compare the chromosome error rate among oocytes from stimulated ovaries after retrieval of 1-5 oocytes, 6-10 oocytes, and >10 oocytes.

Design: Retrospective cohort study.

Setting: A university-based human genetic institute in collaboration with a private fertility center.

Patient(s): Nine hundred thirty-three women undergoing intracytoplasmic sperm injection (ICSI) with a poor prognosis.

Intervention(s): Oocyte collection with ovarian stimulation. Polar body testing of ICSI oocytes for common chromosome errors.

Main outcome measure(s): Chromosome error rate in oocytes, as determined by five-color fluorescence in situ hybridization.

Result(s): In women less than 35 years and women between 35 and 40 years undergoing the first ICSI cycle, oocytes from the high-yield group had an increased likelihood for detectable chromosome errors (50.9% and 54.6%, respectively), compared to the intermediate-yield group (34.9% and 43.8%) and the low-yield group (23.3% and 41.2%). The overall high rate (>or=50%) of chromosomally abnormal oocytes in women more than 40 years appeared to be mainly due to the maternal age effect and increased only slightly with oocyte yield.

Conclusion(s): Oocyte yield may be considered as an indicator of ovarian response to hormone stimulation. In women up to 40 years a high yield of oocytes after superovulation is associated with an increased chromosome error rate.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chromosome Aberrations / chemically induced*
  • Cohort Studies
  • Female
  • Fertility Agents, Female / adverse effects*
  • Humans
  • In Situ Hybridization, Fluorescence
  • Maternal Age
  • Oocyte Retrieval*
  • Ovulation Induction / adverse effects*
  • Pregnancy
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic*
  • Treatment Outcome

Substances

  • Fertility Agents, Female